From ABN AMRO Morgan Biotech-Healthcare Snippets and Tips
Idea Of the Week
Avexa(AVX)- AGM next week should provide some good insights. Buy, Price Target-$1.36, share price 67c, Market Cap: $A272m. Avexa's AGM is on November 20. We expect that the company will update on the planned start of the Phase 3 trial for it's HIV compound. We believe the Phase 3 trial will commence 1QCY08. An update on patient recruitment, centres, progress with the FDA on protocols should give the share price another boost.
AVX Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
